United States · FDA National Drug Code directory

Tizanidine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0914_2ea6e19f-4a23-453c-b9e0-3a7a6a1be92e
Product NDC
71335-0914
Form
TABLET
Composition / generic term
Tizanidine
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20130401
Source listing expiry
20261231

Source-listed ingredients

  • TIZANIDINE HYDROCHLORIDE — 4 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 112 TABLET in 1 BOTTLE (71335-0914-0) · 71335-0914-0
  • 30 TABLET in 1 BOTTLE (71335-0914-1) · 71335-0914-1
  • 60 TABLET in 1 BOTTLE (71335-0914-2) · 71335-0914-2
  • 90 TABLET in 1 BOTTLE (71335-0914-3) · 71335-0914-3
  • 120 TABLET in 1 BOTTLE (71335-0914-4) · 71335-0914-4
  • 20 TABLET in 1 BOTTLE (71335-0914-5) · 71335-0914-5
  • 45 TABLET in 1 BOTTLE (71335-0914-6) · 71335-0914-6
  • 140 TABLET in 1 BOTTLE (71335-0914-7) · 71335-0914-7
  • 84 TABLET in 1 BOTTLE (71335-0914-8) · 71335-0914-8
  • 28 TABLET in 1 BOTTLE (71335-0914-9) · 71335-0914-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →